QTTB · Q32 Bio Inc. · Executive Compensation

$10.53 -0.61 (-5.47%) At close · Sep 10

Market Cap

$331.63M

29.77M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jodie Morrison	Chief Executive Officer and Director	$645,600	—	$335,280	$220,792	$355,080	$2,118	$1,558,870
Lee Kalowski	Chief Financial Officer and President	$565,000	—	$135,255	$59,122	$226,000	$1,770	$987,147
Shelia Violette	Chief Scientific Officer	$455,000	—	$95,250	$37,312	$182,000	$4,884	$774,446

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jodie Morrison	Chief Executive Officer and Director	$627,112	—	—	$5,142,498	$230,802	$2,826	$6,003,238
Lee Kalowski	Chief Financial Officer and President	$432,442	—	—	$2,103,216	$146,900	$171,451	$2,854,009
Jason Campagna	M.D., Ph.D. Chief Medical Officer	$494,854	—	—	$921,568	$130,000	$3,066	$1,549,488
Paul Alloway	Ph.D., J.D. Former President, Chief Operating Officer and Secretary	$115,049	$269,748	—	—	—	$373,342	$758,139

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Jodie Morrison	Chief Executive Officer and Director	$525,032	—	—	$223,275	$327,000	$600	$1,075,907
Paul Alloway	Ph.D., J.D. Former President, Chief Operating Officer and Secretary	$468,189	$92,485	$43,200	$173,889	—	$8,700	$786,463
Jason Campagna	M.D., Ph.D. Chief Medical Officer	$459,680	—	—	—	$220,647	$600	$680,927

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arthur Tzianabos	Chairman of the Board and former Chief Executive Officer	$437,151	—	$157,180	$603,575	$362,100	$112,055	$1,672,061
Albert Seymour	Chief Executive Officer	$527,554	—	$87,430	$323,003	$250,800	$8,700	$1,197,487
W. Bradford Smith	Chief Financial and Business Officer and Treasurer	$460,900	$66,094	$56,910	$217,287	$184,360	$8,700	$994,251
Paul Alloway	Ph.D., J.D. Chief Legal Officer and Secretary	$415,700	$70,771	$43,360	$163,828	$166,280	$8,700	$868,639

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arthur Tzianabos	Chairman of the Board and former Chief Executive Officer	$583,100	—	$578,760	$2,116,074	$320,705	$8,700	$3,607,339
W. Bradford Smith	Chief Financial and Business Officer and Treasurer	$445,300	$120,000	$275,600	$1,016,382	$178,120	$12,377	$2,047,779
Albert Seymour	Chief Executive Officer	$450,000	—	$179,140	$649,818	$180,000	$8,700	$1,467,658

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arthur Tzianabos	President and Chief Executive Officer	$563,200	—	—	—	$309,760	$13,000	$885,960
Albert Seymour	Chief Scientific Officer	$426,800	—	—	—	$170,720	$10,057	$607,577
W. Bradford Smith	Chief Financial Officer	$406,700	—	—	—	$162,680	$13,000	$582,380

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arthur Tzianabos	President and Chief Executive Officer	$537,600	—	—	$4,217,097	$295,680	$12,500	$5,062,877
Albert Seymour	Chief Scientific Officer	$405,600	—	—	$1,295,756	$162,240	$13,231	$1,876,827
W. Bradford Smith	Chief Financial Officer	$384,200	—	—	$1,307,536	$153,680	$14,880	$1,860,296

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arthur Tzianabos	President and Chief Executive Officer	$490,500	—	—	$3,562,722	$250,000	$9,893	$4,313,115
Albert Seymour	Chief Scientific Officer	$386,948	—	—	$1,574,473	$156,760	$5,576	$2,123,757

Executive changes

Person	Role	Change	Effective	Filed
Adrien Sipos, M.D., Ph.D.	Interim Chief Medical Officer	Appointed	2025-07-09	2025-06-25
Jason Campagna, M.D., Ph.D.	Chief Medical Officer	Resigned	2025-07-09	2025-06-25
Mark Iwicki	member of the board of directors	Resigned	2025-12-31	2025-04-25

Key facts CIK 1661998 CUSIP 746964105 13F (30d) 51 filings 51 filers Visit website Investor relations